Results
621
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
621 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
RHM | €894.20 | -4.0% | 112.0% | €38.8b | €862.93 | PE56.7x | E30.5% | 0.6% | Capital Goods | ||
600760 | CN¥45.36 | -0.09% | 19.1% | CN¥126.5b | CN¥53.90 | PE50.8x | E29.4% | 0.6% | Capital Goods | ||
ONON | US$48.44 | -6.9% | 47.7% | US$15.5b | US$63.62 | PE110.3x | E30.2% | n/a | Consumer Durables | ||
NVDA | US$134.43 | -3.2% | 70.0% | US$3.3t | US$172.22 | PE52.2x | E21.6% | 0.03% | Semiconductors | ||
ARES | US$174.09 | -6.5% | 32.6% | US$54.5b | US$198.57 | PE79.7x | E41.4% | 2.6% | Diversified Financials | ||
9992 | HK$109.70 | 1.0% | 459.1% | HK$143.4b | HK$102.94 | PE88.8x | E37.1% | 0.3% | Retail | ||
ALNY | US$250.59 | -2.3% | 57.9% | US$32.4b | US$301.27 | PS14.4x | E59.1% | n/a | Pharmaceuticals & Biotech | ||
6181 | HK$531.50 | 18.4% | n/a | HK$92.3b | HK$502.07 | PE103.3x | E41.9% | n/a | Consumer Durables | ||
300308 | CN¥114.50 | -0.9% | 7.6% | CN¥131.2b | CN¥192.85 | PE27.3x | E33.3% | 0.3% | Tech | ||
NU | US$10.82 | -21.0% | 0.9% | US$52.0b | US$14.89 | PB6.8x | E27.6% | n/a | Banks | ||
ALAB | US$85.72 | -2.4% | n/a | US$13.9b | US$124.53 | PS35.1x | E61.1% | n/a | Semiconductors | ||
A012450 | ₩664,000.00 | 15.1% | 259.7% | ₩30.0t | ₩614,150.00 | PE44.6x | E30.0% | 0.3% | Capital Goods | ||
2382 | NT$264.50 | 1.5% | 9.8% | NT$1.0t | NT$358.05 | PE18.8x | E20.8% | 3.4% | Tech | ||
2345 | NT$705.00 | -7.0% | 35.6% | NT$403.0b | NT$870.00 | PE40.5x | E33.7% | 1.4% | Tech | ||
A196170 | ₩383,000.00 | -3.9% | 144.6% | ₩20.9t | ₩565,000.00 | PS274.4x | E140.6% | n/a | Pharmaceuticals & Biotech | ||
300502 | CN¥113.50 | -7.9% | 86.9% | CN¥85.8b | CN¥161.36 | PE42.2x | E36.6% | 0.1% | Tech | ||
SMCI | US$56.07 | 17.0% | -36.0% | US$32.8b | US$47.88 | PE27.2x | E27.6% | n/a | Tech | ||
PME | AU$283.31 | 0.3% | 185.2% | AU$29.9b | AU$254.50 | PE301.2x | E23.6% | 0.2% | Healthcare | ||
BAM | CA$83.31 | -1.7% | 50.2% | CA$134.5b | CA$76.13 | PE175.1x | E67.5% | 3.0% | Diversified Financials | ||
600989 | CN¥15.80 | -2.1% | 6.5% | CN¥115.1b | CN¥21.74 | PE18.4x | E38.5% | 1.8% | Materials | ||
ITCI | US$128.60 | 0.6% | 79.7% | US$13.7b | US$132.73 | PS20.1x | E50.0% | n/a | Pharmaceuticals & Biotech | ||
KSPI | US$102.15 | -6.4% | -1.1% | US$19.4b | US$132.85 | PE10x | E20.8% | 6.6% | Diversified Financials | ||
BAJFINANCE | ₹8,396.70 | 0.05% | 25.4% | ₹5.2t | ₹8,664.82 | PE32.5x | E23.4% | 0.4% | Diversified Financials | ||
SYM | US$24.47 | -9.6% | -40.3% | US$14.4b | US$34.32 | PS1.4x | E84.6% | n/a | Capital Goods |